Nano Dimension Ltd - ADR vs Tempus AI — how do they compare? Nano Dimension Ltd - ADR trades at $1.65 (market cap $350.49M), while Tempus AI trades at $54.53 (market cap $10.05B). The key difference: Tempus AI is far larger — about 28.7× Nano Dimension Ltd - ADR's market cap, and Nano Dimension Ltd - ADR is trading nearer its 52-week high, Tempus AI nearer its low. Which is the better fit depends on your goals.
| NNDM | TEM | |
|---|---|---|
Market Cap | $350.49M | $10.05B |
Sector | Technology | Broad Market / Factor |
52-Week High | $2.14 | $103.25 |
52-Week Low | $1.21 | $41.55 |
Enterprise Value | -$54.35M | $10.68B |
Signals from Pluang's Aura AI — not financial advice
NNDM trades at $1.655, up 1.53% today, with a bullish technical signal from moving averages but bearish oscillators. The company reported Q2 2026 EPS of -$0.03, beating expectations, while revenue grew to $102.44M in 2025. However, net income remains deeply negative at -$293.30M, and cash flow from operations is negative. Recent strategic moves include selling MarkForged to Stratasys and cost-saving initiatives to reduce cash burn.
Outlook: Potential upside from strategic divestitures and cost cuts, but high execution risk and persistent losses pose significant challenges. Investors should weigh the low P/B of 0.73 against sustained profitability concerns and shareholder disputes highlighted in recent news.
Tempus AI (TEM) trades at $54.61, down 0.82% with a bullish technical outlook despite negative profitability. The company shows strong revenue growth with 2026 revenue guidance raised to $1.4B, though net losses persist. Recent Q2 earnings beat expectations with a narrower loss of $0.04 per share versus $0.14 expected. Technical indicators show bullish momentum with support at $54 and resistance at $57.
Investment outlook balances growth potential against profitability challenges. Analyst consensus is strongly bullish with 61.5% buy ratings and $61.57 price target, representing 13% upside. Key risks include sustained negative cash flow from operations and high valuation multiples amid ongoing losses. The Personalis acquisition expands MRD testing capabilities but integration execution remains a watchpoint.
Trailing returns across standard periods
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →